After Receiving
LUTATHERA® (lutetium Lu 177 dotatate)

Things to do after receiving LUTATHERA

Since LUTATHERA is a nuclear medicine therapy, there are some things you should do to keep everyone safe and minimize exposure to family members and the general public.

At the hospital:

  • While you are taking LUTATHERA, you will be kept away from other patients in the hospital to limit their exposure. Your family members and caregivers may be with you during your treatment away from other patients or staff, but they may be asked to leave for 30 to 40 minutes while LUTATHERA is being given.

After leaving the hospital:

  • Your healthcare provider may provide further instructions to help minimize radiation exposure to others. You should always follow your healthcare provider’s instructions.

LUTATHERA® Treatment Card:

  • Your healthcare provider may fill out a LUTATHERA treatment card and give it to you after treatment. This card will list your name, the amount of medicine that you received, and a hospital contact name and phone number. You should keep this card with you for a few days after your treatment, especially if you are traveling through an airport.


LUTATHERA® (lutetium Lu 177 dotatate) is a prescription medicine used to treat adults with a type of cancer known as gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin, including GEP-NETs in the foregut, midgut, and hindgut.

Patient Discussion Guide
You are now leaving the website. Advanced Accelerator Applications USA, Inc. is not responsible for the content on external websites.